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Abstract 
Intervertebral disc (IVD) degeneration is the leading trigger of low back pain, which causes 
disability and leads to enormous healthcare toll worldwide. Biological treatment with growth 
factors has evolved as potential therapy for IVD regeneration. Bone morphogenetic protein 2 
(BMP-2) and BMP-7 have shown promise in this regard. In the current study, we evaluated 
the effect of BMP-2/7 heterodimer for disc regeneration both in vitro and in organ culture. 
Nucleus pulposus (NP) cells isolated from bovine caudal disc were cultured in a fibrin-
hyaluronan (FBG-HA) hydrogel for up to 14 days. BMP-2/7 heterodimer covalently 
incorporated within the hydrogel up-regulated the aggrecan and type II collagen gene 
expression, and glycosaminoglycan synthesis of NP cells. The activity of the BMP-2/7 
heterodimer was dose dependent. A higher dose of BMP-2/7 was further assessed in an IVD 
whole organ system. After 14 days of culture with cyclic dynamic load, the BMP-2/7 
heterodimer delivered into the nucleotomized region showed potential to stimulate the gene 
expression and synthesis of proteoglycan in the remaining NP tissue after partial nucleotomy. 
The gene expression level of type I collagen and alkaline phosphatase in the native disc tissue 
were not affected by BMP-2/7 treatment, indicating no adverse fibroblastic or osteogenic 
effect on the disc tissue. Intradiscal delivery of BMP-2/7 heterodimer may be a promising 
therapeutic approach for NP regeneration. The current IVD whole organ partial nucleotomy 
model may be utilized for screening of other biomaterials or drugs to treat early degenerated 
disc.           
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Introduction 
The intervertebral disc (IVD) is composed of the central gel-like nucleus pulposus (NP), the 
surrounding annulus fibrosus (AF), and the cartilaginous endplates that anchor the discs to the 
adjacent vertebrae1. The main functions of the IVD are to provide flexibility to the spine, and 
to transmit the mechanical load. Low back pain caused by IVD degeneration is the leading 
cause of disability worldwide2. Biological approaches for treatment of IVD degeneration have 
evolved in the last decade, including the use of recombinant or natural proteins that can lead 
to the restoration of the native healthy disc3; 4. 
Bone morphogenetic proteins (BMPs) are involved in a wide variety of developmental 
processes, including bone, cartilage and IVD formation5; 6. In particular, BMP-2 and BMP-7 
have been investigated in musculoskeletal research and have demonstrated promising 
potential for IVD regeneration. BMP-2 can up-regulate the gene expression and protein 
synthesis of extracellular matrix components in rabbit NP cells7, and human NP cells8; 9 
cultured in vitro. In a rabbit in vivo study, treatment with adeno-associated viral vector 
carrying the gene for BMP-2 delayed the degeneration process in annulotomized discs10. 
BMP-7 was found to stimulate extracellular matrix synthesis in NP cells and AF cells from 
rabbit11; 12 and human13 origin. It also inhibited cellular apoptosis, induced by tumor necrosis 
factor-alpha, in human NP cells14. The effect of BMP-7 for IVD regeneration has furthermore 
been explored in small animal models, including rat15; 16, rabbit17-19 and canine20. These 
studies revealed that intradiscal delivery of BMP-7 could restore disc height, stimulate 
extracellular matrix formation and prevent degeneration in the IVD.  
Several studies have demonstrated that heterodimeric BMP-2/7 had a stronger activity for 
bone regeneration compared with BMP-2 or BMP-7 homodimers21; 22. Thus in this study, we 
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investigated the effect of heterodimeric BMP-2/7 on the regeneration of the NP. In addition, 
the BMP-2/7 heterodimer was covalently incorporated within a fibrin-hyaluronan (FBG-HA) 
conjugate hydrogel23, in order to obtain a slow release and prevent ectopic leakage. The dose 
dependent effects of the BMP-2/7 heterodimer on the proliferation and extracellular matrix 
synthesis of bovine NP cells were first tested in vitro in a three-dimensional FBG-HA 
hydrogel. Then the effect of the BMP-2/7 heterodimer, covalently bound to the FBG-HA 
hydrogel, on IVD regeneration was evaluated ex vivo in a bovine IVD whole organ culture 
nucleotomy model.  
 
Methods 
1. BMP-2/7 heterodimer production 
BMP-2/7 heterodimer was produced as described previously 23. The BMP-2/7 heterodimer 
contained extra amino acids for transglutaminase crosslinking and plasmin cleavage sites at 
the N terminus. This manipulation facilitates the covalent binding of BMP-2/7 to fibrin or 
fibrin-like materials and cell-demanded growth factor release 23. Briefly, recombinant human 
BMP-2 including amino acids for transglutaminase and plasmin cleavage sites (TG-BMP-2) 
was cloned and expressed in E. coli. TG-BMP-2 monomers were purified with affinity and 
size exclusion chromatography. TG-BMP-2 and BMP-7 monomers were then refolded in a 
buffer with CHAPS (3((3-cholamidopropyl)-dimethylammonio)-propansulfonate) and 
glutathione. In a final purification step, BMP-2/7 heterodimers were separated from unfolded 
monomers and BMP-2 homodimers.  
 
2. Fabrication of FBG-HA conjugate hydrogel 
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A FBG-HA conjugate hydrogel, which had been shown to promote NP cell growth and matrix 
production24, was used for BMP-2/7 heterodimer delivery. Fibrinogen-HA conjugate solution 
was synthesized with 235 KDa HA at FBG/HA w/w ratio of 17:1 via a two-step procedure as 
described elsewhere 24. FBG-HA hydrogels were prepared by mixing 2/3 volume of FBG-HA 
conjugate solution with 1/3 volume of thrombin solution (5.2 U/mL) and allowed to 
polymerize at 37ºC for 20 min. 
 
3. Effect of BMP-2/7 heterodimer on NP cells in vitro 
3.1. Experimental set-up 
An in vitro cell culture experiment was performed to determine the potential of BMP-2/7 at 
different doses for promoting the metabolic activity and function of NP cells. NP cells were 
isolated from 4-10 months old bovine caudal discs as previously described 24. Primary NP 
cells were encapsulated within FBG-HA conjugate hydrogel beads at a density of 1.2 x 105 
cells per bead (4 x 106 cells/mL). Each bead had a volume of 30 µL and was prepared by 
mixing 20 µL of FBG-HA conjugate, containing NP cells in suspension, with 10 µL of 
thrombin containing different concentrations of BMP-2/7. The final concentrations of BMP-
2/7 in the FBG-HA hydrogels were 0 (hydrogel control), 1000 ng/mL, and 5000 ng/mL. Cell–
gel constructs were cultured in Dulbecco's Modified Eagle Medium (DMEM, with 4.5 g/L 
glucose) with 2% fetal calf serum (FCS), 100 U/mL penicillin and 100 μg/mL streptomycin (1% 
Pen/Step) (all products from Gibco, Praisley, UK), 1% ITS+ Premix (Discovery Labware, 
Inc., Bedford, USA) and 50 μg/mL ascorbate-2-phosphate (Sigma-Aldrich, St. Louis, USA) 
for 7 or 14 days. The cell culture medium was changed three times per week. 
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3.2. Gene expression analysis 
Total RNA extraction from NP cells in hydrogels was performed with TRI Reagent 
(Molecular Research Center, OH, USA) after 7 and 14 days of culture. Reverse transcription 
was carried out with TaqMan™ reverse transcription reagents (Applied Biosystems, CA, 
USA) using random hexamer primers and 0.5 μg of total RNA. Real-time PCR was 
performed using the Step-One-Plus instrument (Applied Biosystems). Table 1 shows the 
sequences of custom designed bovine primers and TaqMan probes (Microsynth, Balgach, 
Switzerland) for collagen type I (COL1A2), collagen type II (COL2A1) and aggrecan 
(ACAN). For amplification of 18S ribosomal RNA, a gene expression assay from Applied 
Biosystems was used (18S, 4310893E). The comparative Ct method was performed for 
relative quantification of target mRNA with 18S rRNA as endogenous control. 
 
3.3. Glycosaminoglycan (GAG) and DNA content  
On day 7 and day 14, the cell–gel constructs were digested with 0.5 mg/mL proteinase K at 
56°C overnight. The GAG content in the hydrogels was measured using the 1,9-
dimethylmethylene blue dye (DMMB) method 25 and was normalized to the DNA content in 
respective samples. GAG content in hydrogels on day 0 were subtracted from all the samples. 
The DNA content in the hydrogels was measured by PicoGreen assay (Invitrogen, Eugene, 
Oregon, USA) according to the manufacturer’s instruction. 
 
4. Effect of BMP-2/7 heterodimer on IVDs with NP replacement under dynamic loading 
ex vivo 
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4.1 Dissection of bovine caudal IVDs 
For assessment of the BMP-2/7 heterodimer in an IVD organ culture system, which supplies a 
microenvironment close to the in vivo situation, bovine caudal spines (4-10 months) were 
obtained from local abattoirs and harvested aseptically within three hours after death. After 
removal of the soft tissue, IVDs including the cartilaginous endplates were dissected with a 
band saw (model 30/833, Exakt Apparatebau, Norderstedt, Germany) and cleaned with a 
Pulsavac jet-lavage system (Zimmer, IN, USA) 24. Initial disc height and diameter were 
measured with a caliper before discs were washed with phosphate buffered saline (PBS) 
containing 1000 U/mL penicillin and 1000 μg/mL streptomycin for 15 min. Then discs were 
transferred to a 6-well plate containing disc culture medium (DMEM 4.5g/L glucose supplied 
with 2% FCS, 1% Pen/Strep, 1% ITS+ Premix, 50 μg/mL ascorbate-2-phosphate and 0.1% 
Primocin) and incubated overnight at 37°C, 85% humidity and 5% CO2. After dissection, disc 
height of all bovine IVDs in this study ranged from 7 to 14 mm and disc diameter ranged 
from 13 to 20 mm. 
 
4.2      Partial nucleotomy and NP replacement in organ cultured IVDs 
A partial nucleotomy was performed mechanically as described previously 24. To reach a 
similar nucleotomy ratio of approximately 50% of the total NP volume for different sizes of 
discs, a NP cavity with diameter of 4 mm was created in small discs with diameter of 13-16.5 
mm; in discs with diameter of 16.5-20 mm, a NP cavity with diameter of 6 mm was created. 
Discs were nucleotomized through the endplate by central incisions using a biopsy punch of 4 
or 6 mm diameter and a number 11 blade. After removing an endplate core, the NP tissue 
below the endplate core until the distal endplate was excised. After partial nucleotomy, 50–80 
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μL of FBG-HA hydrogel containing 0 or 5000 ng/mL BMP-2/7 were pipetted into the 
nucleotomized region. Our previous study had shown that the FBG-HA hydrogel alone was 
not sufficient to restore the axial stiffness of partially nucleotomized discs under dynamic 
load24. Therefore, a polyurethane (PU) scaffold (kindly supplied by Nicast Ltd., Lod, Israel) 
with swelling ability in situ26 was subsequently placed into the FBG-HA hydrogel in the NP 
cavity. The PU scaffold was composed of a water absorbable core and an electrospun 
envelope. It has been used as a NP replacement material in this IVD organ culture nucleotomy 
model, thereby filling the nucleotomized region and restoring the mechanical property of 
nucleotomized IVDs 26. After implantation of the biomaterials, the removed endplate stopper 
was immediately re-inserted, and the crack between the stopper and the remaining endplate 
was sealed by polymethyl methacrylate (Vertecem Mixing Kit, Synthes, Teknimed S.A., 
Bigorre, France) according to manufacturer’s instruction. For each disc, approximately 100–
150 mg of polymethyl methacrylate was applied. 
 
4.3      Dynamic load on IVDs within bioreactor  
To mimic physiologically relevant conditions in organ cultures, dynamic loading was applied 
on the IVDs with a bioreactor system 27. IVDs were placed in custom made chambers filled 
with disc culture medium, and loaded dynamically for 3 hours/day at 0-0.1 MPa and 0.1 Hz. 
After dynamic loading IVDs were cultured free swelling in 6-well plates overnight. The 
repetitive dynamic loading and free swelling culture was applied for 14 consecutive days. The 
experiments were performed using bovine IVDs from 12 tails, with 2 discs from each tail 
randomly assigned to one of the two experiment groups: FBG-HA without BMP2/7, or FBG-
HA with 5000 ng/mL BMP2/7. 
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4.4      Disc height change  
Disc height was measured with a caliper at different time points: day 0 after dissection, day 1 
after 1st load, day 2 after 1st recovery, day 7 after 7th load, day 8 after 7th recovery, day 14 
after 14th load, and day 15 after 14th recovery. Each disc was measured at four positions and 
the mean value was used to calculate the percentage of disc height change. Disc height change 
was normalized to the initial dimension after dissection. 
 
4.5      Biological evaluations 
After 14 days of culture with repetitive dynamic loading and free swelling recovery, 
cartilaginous endplates of each disc were removed, and remaining NP and AF tissues were 
harvested by using a biopsy punch and scalpel, respectively. Approximately 100 mg of each 
AF and NP was used for mRNA extraction; 50 mg was digested with 0.5 mg/mL proteinase K 
at 56°C overnight for glycosaminoglycan (GAG), collagen and DNA content measurement; 
and 30 mg of NP was used for [35S] sulfate incorporation assay to assess proteoglycan 
synthesis rate.  
 
Gene expression analysis 
Tissue samples were flash frozen, pulverized in liquid N2, and homogenized using a 
TissueLyser (Qiagen, Venlo, The Netherlands). Total RNA was extracted with TRI Reagent 
and reverse transcription was performed with SuperScript VILO cDNA Synthesis Kit (Life 
Technologies, Carlsbad, CA). Quantitative real-time PCR was performed using the Step-One-
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Plus instrument. The sequences of custom designed bovine primers and TaqMan probes are 
shown in Table 1. For amplification of 18S ribosomal RNA, Versican (Bt03217632_m1), 
Biglycan (BGN, Bt 03244532_m1) and Alkaline Phosphatase (ALPL, Bt03244508_m1), gene 
expression assays from Applied Biosystems were used. The comparative Ct method was 
performed for relative quantification of target mRNA with 18S rRNA as endogenous control. 
 
GAG, collagen, and DNA content  
The GAG content in the NP and AF tissue was determined by using the DMMB method as 
mentioned above. The total amounts of collagen in NP and AF samples were measured using 
a quantitative Hydroxy-Proline assay as described earlier28. DNA content was measured 
spectrofluorometrically using Hoechst (33258) dye.  
 
35S sulfate incorporation rate  
NP tissue was incubated for 16-20 hours in disc culture medium supplemented with 2.5 µCi 
35S-sulfate /mL (Na2 35SO4; PerkinElmer, Schwerzenbach, Switzerland). Thereafter NP tissue 
was digested with 0.5 mg/mL proteinase K at 56°C overnight. Conditioned medium and 
proteinase K digested tissue samples were analyzed after PD-10 desalting column (GE 
Healthcare, Glattbrugg, Switzerland) and radioactive counts were measured by Wallac 1414 
Liquid Scintillation Counter (PerkinElmer, Schwerzenbach, Switzerland). Finally the counts 
per minute (cpm) were normalized to the DNA content of the respective samples. 
 
4.6      Safranin O/Fast Green staining  
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After 14 days of culture with repetitive dynamic loading and free swelling recovery, whole 
discs with implanted biomaterials were fixed in 70% methanol and transferred into PBS with 
5% sucrose at 4˚C overnight before cryosectioning. Transverse sections of IVDs were cut at a 
thickness of 12 µm. Sections were stained with 0.1% Safranin-O and 0.02% Fast Green to 
reveal proteoglycan and collagen deposition, respectively, and counterstained with Weigert's 
Haematoxylin to reveal cell distribution. 
 
4.7      Fourier transform infrared (FTIR) microscopic imaging 
After 14 days of culture with repetitive dynamic loading and free swelling recovery, a set of 
discs were decalcified and subsequently embedded in paraffin. Four micrometre sagittal IVD 
sections were cut and mounted on custom made reflective 316 stainless steel slides for 
infrared analysis. FTIR microscopic images were collected using an Agilent 680-IR FTIR 
spectrometer (ISys50®, Malvern Instruments Limited, Worcestershire, UK) coupled to a 
FTIR imaging microscope fitted with a liquid nitrogen cooled 64 x 64 mercury-cadmium-
telluride focal plane array detector (FPA) and an automated sampling stage. For each sample, 
an area of 71 x 192 pixels (approximately 6.3 x 16.8 mm) was mapped in transflectance mode. 
Spectra were attained with a spectral resolution of 4 cm-1 over a wavenumber range of 950-
1900 cm-1. Data was pre-processed by performing a second derivative (Savitsky-Golay 
ISys50 software, Filter order 3, filter length 15) on the spectra to reduce baseline effects and 
assist the resolution of weaker absorption peaks29. Pixels within the tissue section where 
spectra indicated only the presence of paraffin or the substrate were identified and masked 
using spectral statistics (ISys50, histogram). Regions of interest (ROI; 10 x 192 pixels) across 
the middle of each sagittal section were cut and compiled to one data matrix. The data set was 
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analyzed using a multivariate curve resolution-alternating least squares algorithm (MCR-ALS) 
described by Andrew and Hancewicz 30 and Wang et.al. 31. MCR-ALS was carried out using 
the MCR-ALS v1.6 software (MCRv1.6 Copyright © 2003-2004 Unilever) on two 
wavenumber regions of 950-1600 cm-1 and 950-1300 cm-1 with the following settings; initial 
estimates: 4 -10F, NIPALS, ALS; ALS constraints: MALS-2D, none, 1e-005, 500. General 
tissue, collagen type I, collagen type II and proteoglycan distributions were estimated 
according to previous studies that have shown good agreement between (immuno-) 
histological staining and the integrated peak area of the 2nd derivative of the amide III 
spectral region (1186-1297 cm-1) as well as MCR-ALS score maps 32. Additionally, average 
matrix component per tissue distribution across ROIs were calculated and are represented as 
estimated component per tissue distribution line profiles across the normalized width (0-100%) 
of each IVD.  
 
5. Statistical analysis 
SPSS 21.0 statistical software was used for statistical analysis. One sample Kolmogorov–
Smirnov test was used to define whether the data were normally distributed (normal 
distribution at p > 0.1). For data that were normally distributed, one-way ANOVA with Tukey 
post hoc test was used to determine differences among three or more different groups, 
unpaired T test was used to determine differences between two groups. For data that were not 
normally distributed, Kruskal-Wallis test was used to determine differences among three or 
more different groups, Mann-Whitney U test was used to determine differences between two 
groups. A p-value <0.05 was considered statistically significant; p-value <0.1 was considered 
to indicate a trend. 
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Results 
1. Effect of BMP-2/7 heterodimer on NP cells in vitro 
The ACAN, COL1A2 and COL2A1 gene expression levels of NP cells encapsulated in FBG-
HA hydrogels after 7 or 14 days of culture were normalized to the expression levels of cells at 
day 0 (after isolation from NP tissue and before 3D culture, Fig. 1 A). On day 7, there was a 
trend of higher ACAN expression in hydrogels containing 5000 ng/mL of BMP-2/7 compared 
with hydrogels without (p=0.065) and with 1000 ng/mL (p=0.067) of BMP-2/7. On day 14, a 
trend of higher COL2A1 expression was observed in hydrogels containing 5000 ng/mL of 
BMP-2/7 compared with hydrogels without (p=0.085) and with 1000 ng/mL (p=0.053) of 
BMP-2/7. 
The cell proliferation was not affected by BMP-2/7 incorporation into the hydrogel (Fig. 6 B); 
while the GAG amounts synthesized per cell (GAG/DNA value) were significantly increased 
in hydrogels with 1000 or 5000 ng/mL BMP-2/7 after 7 days of culture (Fig. 1 C; p<0.05).  
 
2. Effect of BMP-2/7 heterodimers on IVDs with NP replacement under dynamic 
loading ex vivo 
2.1       Disc height change 
A diurnal disc height change pattern was observed during the entire period of 14 days of 
repetitive dynamic load (Fig. 2 A). Compared with the initial disc height after dissection, a 
disc height loss of -3.6% to -0.3% was observed after 3 hours of dynamic loading. After 
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overnight free swelling, the discs height recovered, whereby an increase of 4.7% to 11.7% 
was observed.     
 
2.2      Gene expression  
Gene expression levels after 14 days of culture with dynamic load were compared to the 
expression levels of disc tissue from respective bovine tails before starting organ culture on 
day 0 (Fig. 2 B and C). Compared with day 0, the gene expression of ACAN in NP tissue of 
discs with hydrogel, but without BMP-2/7 implantation, did not change. When FBG-HA 
hydrogel containing BMP-2/7 was implanted, the gene expression of ACAN in NP tissue 
increased 4.5-fold (p = 0.083, Fig. 2 B). Compared with day 0, gene expression of COL2, 
COL1, MMP13, and ALPL increased, while gene expression of BGN decreased in the NP 
tissue of discs without BMP-2/7. The implantation of FBG-HA hydrogel containing BMP-2/7 
did not show significant effects on the expression of these genes in the NP tissue (Fig. 2 B). 
Compared with day 0, gene expression of ACAN, COL1, MMP13, ALPL and Versican 
increased, while gene expression of COL2 decreased in the AF tissue of discs without BMP-
2/7. The implantation of FBG-HA hydrogel containing BMP-2/7 did not show significant 
effects on the expression of these genes in the AF tissue (Fig. 2 C). 
 
2.3      Biochemical analysis 
GAG content, collagen content and PG synthesis rate per cell of native NP and AF tissue in 
partially nucleotomized discs treated with hydrogel with/without BMP-2/7 incorporation are 
shown in Table 2. In the remaining NP tissue in contact with the hydrogel-growth factor 
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implants, the GAG/DNA ratio increased by 46% when BMP-2/7 was incorporated (p=0.113). 
The Collagen/DNA ratio and PG synthesis rate/DNA ratio were not affected by addition of 
BMP-2/7 to the hydrogel. In the AF tissue, neither GAG/DNA ratio nor Collagen/DNA ratio 
was affected by BMP-2/7 incorporation. 
 
2.4      Histological analysis of whole discs  
Images of Safranin O/Fast Green stained transverse sections of discs cultured for 14 days are 
shown in Figure 3. In line with a previous study on the PU scaffold for NP replacement26, the 
swollen PU scaffold filled the nucleotomized region completely (Fig. 3 A, C). The envelope 
of the PU scaffold was observed as a ring in direct contact with the remaining disc NP tissue. 
The core of the PU scaffold essentially consists of water and therefore appears as an empty 
non-stained region in the center of the disc section. Part of the FBG-HA hydrogel 
with/without BMP-2/7 diffused into the envelope of the PU scaffold, as indicated by the 
intense red Safranin-O staining due to the HA component in the hydrogel (Fig. 3 B, D). The 
remaining native disc NP tissue continued to present intense proteoglycan staining with 
Safranin O after 14 days of culture with dynamic load. 
    
2.5       FTIR imaging analysis of disc tissue 
An example of an image reflecting the tissue distribution (sagittal direction) of a paraffin 
embedded partially nucleotomized disc treated with hydrogel without BMP-2/7 (0 ng/mL 
BMP-2/7) cultured for 14 days under dynamic load is shown in Figure 4 A. Tissue 
distribution maps of ROI of partially nucleotomized discs treated with hydrogel without 
BMP-2/7 (top) and with 5000 ng/mL BMP-2/7 (bottom) cultured for 14 days under dynamic 
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load are shown in Figure 4 B. Both ROI tissue images show a cavity in the center of the disc 
where the implant was situated, surrounded by native disc tissue. Estimated component / 
tissue distribution line profiles of proteoglycan, collagen type II and collagen type I across the 
IVD sections display distinctive trends, with proteoglycan and collagen type II profiles 
showing an overall increase and collagen type I profiles revealing a decrease from the outer 
AF region towards the central NP region (Fig. 4 C). A comparison of the line profiles between 
samples treated with hydrogel with and without BMP-2/7 indicates very similar overall trends 
for proteoglycan, collagen type II and collagen type I. However, localized differences in 
proteoglycan distributions can be observed, with the disc treated with 0 ng/mL BMP-2/7 
showing a lower proteoglycan per tissue ratio than the disc treated with 5000 ng/mL BMP-2/7 
in most areas across the disc, apart from two regions at around 26-30 % and 34-38 % IVD 
width. Distribution line profiles of collagen type II for discs treated with 0 ng/mL and 5000 
ng/mL BMP-2/7 show similar but less prominent trends in comparison to the proteoglycan 
distributions. The collagen type I line profile of the disc treated with hydrogel and 0 ng/mL 
BMP, shows more pronounced localized lower component to tissue ratios (sharp negative 
features) at around 6-12 %, 20-45 % and 84-90 % in comparison to the profile of the disc 
treated with hydrogel and 5000 ng/mL BMP-2/7. 
 
Discussion 
Fibrinogen-hyaluronan conjugate hydrogel has previously been evaluated as a favorable 
biomaterial for nucleus pulposus regeneration24. In the present study, we first investigated the 
dose effect of BMP-2/7 covalently incorporated within the FBG-HA hydrogel by 
encapsulating NP cells in the hydrogel and culturing for up to 14 days. The proliferation rate 
Kommentiert [ZLi1]:  
Kerstin, these numbers seem do not correlate with the figure. 
Could you please double check? 
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of the NP cells was not affected by BMP-2/7. Incorporation of BMP-2/7 at the concentration 
of 1000 ng/mL and 5000 ng/mL both stimulated the GAG synthesis after 7 days of culture. In 
addition, NP cells treated with 5000 ng/mL of BMP-2/7 showed higher ACAN gene 
expression level after 7 days, and higher COL2 gene expression level after 14 days, which 
indicates a stimulatory effect on the further production of NP like extracellular matrix after 
another culture period. These results are in line with previous in vitro disc cell culture studies 
performed with BMP-27-9 and BMP-711-13 and further corroborate that BMP-2/7 can stimulate 
the extracellular matrix production of NP cells in 3D culture in vitro. 
Based on the results of the in vitro study, the higher dose of 5000 ng/mL BMP-2/7 was 
selected in the IVD organ culture experiments. After 14 days of culture with repetitive 
dynamic load, BMP-2/7 delivered into the partially nucleotomized disc up-regulated the 
ACAN gene expression level in the remaining NP tissue. The FTIR spectrum also showed 
higher proteoglycan intensity over most areas of the analyzed sagittal IVD sections in the 
BMP-2/7 treated discs. In biochemical analysis, although not significant, the GAG/DNA ratio 
was up-regulated 1.5-fold in the NP tissue and 2.3-fold in the AF tissue with the delivery of 
BMP-2/7. These results indicate that the covalently incorporated BMP-2/7 has the potential to 
stimulate the gene expression and synthesis of proteoglycan components in the NP tissue of 
partially nucleotomized discs. 
A previous study by Huang et al. has reported negative effects after intradiscal injection of 
100 µg BMP-2 into rabbit lumbar discs33. Fibroblastic disc tissue, osteophyte formation, and 
hypertrophy of cartilaginous endplate were observed at 12 weeks after surgery. In the current 
IVD whole organ culture study, the COL1 and ALPL gene expression levels in the native disc 
tissue were not dysregulated by BMP-2/7 treatment. The Safranin O/Fast Green staining also 
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revealed intense proteoglycan staining in the remaining NP tissue after partial nucleotomy and 
BMP-2/7 treatment. These results demonstrate that the BMP-2/7 applied at the current 
concentration (0.25-0.4 µg / disc) and in the formulation of covalent binding to FBG-HA does 
not have adverse fibroblastic or osteogenic effects on the disc tissue. This is consistent with a 
previous study by Kim et al., where the exposure of human disc cells cultured in 3D beads to 
BMP-2 did not result in an osteogenic response, whereas proteoglycan synthesis was 
increased in NP cells9. The dose, the exposed cell type, and the delivery method of growth 
factors play an important role in directing the fate of the cell phenotype. Importantly, leakage 
of growth factor out of the disc space substantially increases the risk for unwanted effects on 
other cell types. The covalent binding of BMP-2/7 to the FBG-HA conjugate hydrogel 
provides a depot of growth factor, avoiding the need for repetitive application, and at the same 
time minimizes the potential for growth factor leakage. 
Although the biochemical analysis revealed higher matrix synthesis and content after 
incorporation of growth factor compared to pure hydrogel delivery, these results did not reach 
statistical significance. An explanation might be the relatively short observation time of two 
weeks in combination with a delivery system that requires hydrogel degradation for growth 
factor release23. Longer culture periods may be needed to detect a significant impact of 
sustained release BMP-2/7 delivery on the tissue matrix level. Furthermore, combinations of 
different growth factors might show superior efficacy. The synergistic effects of BMP and 
other growth factors on disc cells have been investigated by several groups with in vitro 
studies34-37. BMP-7 and insulin like growth factor 1 potentiated anabolic stimulation through 
complementary mechanisms on matrix formation of bovine NP cells compared with treatment 
with either growth factor alone36. Porcine AF cells treated with the combination of BMP-2 
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and transforming growth factor beta 1 caused a greater decrease in MMP-1 and increase in 
aggrecan than either growth factor alone34. In another study, bovine NP cells were cultured 
with BMP-7 and lactoferricin B in alginate35. It was found that lactoferricin B maximizes the 
regenerative activity of BMP-7 by inhibiting noggin. Human degenerative NP cells co-
transfection with BMP-7 and Sox9 also showed a synergistic effect on type II collagen 
transcription37. However, all these studies have been performed using disc cells cultured in 
vitro, thereby lacking the disc tissue and organ specific microenvironment. Further studies 
will be required to elucidate the synergistic effect of BMP and other growth factors for disc 
regeneration. The use of the described IVD whole organ nucleotomy model could bring 
information at higher relevance level for clinical transplantation. 
 
Conclusion 
Covalently incorporated BMP-2/7 heterodimer stimulated the ACAN and COL2 gene 
expression, and GAG synthesis of bovine NP cells cultured in FBG-HA hydrogel. In an IVD 
whole organ model, BMP-2/7 heterodimer delivered into the nucleotomized region has the 
potential to promote the gene expression and synthesis of proteoglycan in the remaining NP 
tissue, without causing adverse fibroblastic or osteogenic induction. Intradiscal delivery of 
BMP-2/7 heterodimer may be a promising therapeutic approach for NP regeneration. The 
current IVD whole organ partial nucleotomy model may be utilized for screening of other 
biomaterials or bioactive factors to treat early degenerated disc.           
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Table 1. Oligonucleotide primers and probes (bovine) used for real-time PCR. 
Gene Primer/probe type Sequence 
COL1A2 Primer fw (5'-3') 
Primer rev (5'-3') 
Probe (5'FAM/3'TAMRA) 
TGC AGT AAC TTC GTG CCT AGC A 
CGC GTG GTC CTC TAT CTC CA 
CAT GCC AAT CCT TAC AAG AGG CAA 
CTG C 
COL2A1 Primer fw (5'-3') 
Primer rev (5'-3') 
Probe (5'FAM/3'TAMRA) 
AAG AAA CAC ATC TGG TTT GGA GAA A 
TGG GAG CCA GGT TGT CAT C 
CAA CGG TGG CTT CCA CTT CAG CTA 
TGG 
ACAN  Primer fw (5'-3') 
Primer rev (5'-3') 
Probe (5'FAM/3'TAMRA) 
CCA ACG AAA CCT ATG ACG TGT ACT 
GCA CTC GTT GGC TGC CTC 
ATG TTG CAT AGA AGA CCT CGC CCT 
CCA T 
MMP13 Primer fw (5'-3') 
Primer rev (5'-3') 
Probe (5'FAM/3'TAMRA) 
CCA TCT ACA CCT ACA CTG GCA AAA 
GTC TGG CGT TTT GGG ATG TT 
TCT CTC TAT GGT CCA GGA GAT GAA 
GAC CCC 
ACAN: aggrecan; COL1A2: collagen type I; COL2A1: collagen type II; MMP13: matrix 
metalloproteinase 13; FAM: Carboxyfluorescein; fw: Forward; rev: Reverse; TAMRA: 
Tetramethylrhodamine 
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Table 2. Biochemical analysis of native disc tissue in partially nucleotomized discs implanted 
with PU scaffolds and FBG-HA hydrogel with/without BMP-2/7 after 14 days of dynamic 
load. Total glycosaminoglycan (GAG) content, total collagen content and proteoglycan (PG) 
synthesis rate were measured and normalized to the DNA content of the respective samples. 
GAG/DNA ratio in µg/µg; Collagen/DNA ratio in µg/µg, PG/DNA in counts per minute 
(CPM)/µg; PG/DNA was measured for NP tissue only. Mean ± SEM, n=6.   
Biochemical analysis of IVD tissue 
NP tissue 
Group 0 ng/mL BMP-2/7 5000 ng/mL BMP-2/7 
GAG / DNA 837.7 ± 172.3 1226.5 ± 129.6 
Collagen / DNA 578.4 ± 313.3 1034.9 ± 277.9 
PG / DNA 62.3 ± 4.6 75.6 ± 15.0 
 
AF tissue 
Group 0 ng/mL BMP-2/7 5000 ng/mL BMP-2/7 
GAG / DNA 305.4 ± 44.9 707.2 ± 142.1 
Collagen / DNA 957.5 ± 119.5 957.1 ± 336.3 
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Figure 1. (A) Relative mRNA expression of ACAN, COL1A2, and COL2A1 of nucleus 
pulposus cells encapsulated in FBG-HA hydrogels with 0, 1000 or 5000 ng/mL BMP-2/7, 
after 7 or 14 days of culture. Data were normalized to the expression level of cells before 
hydrogel culture (day 0). Mean + SEM, n=6. (B) DNA content, and (C) GAG/DNA value 
within nucleus pulposus cells seeded FBG-HA hydrogels with 0, 1000 or 5000 ng/mL BMP-
2/7, after 7 or 14 days of culture. Mean ± SEM, n=6, *p<0.05. 
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Figure 2. (A) Disc height change of partially nucleotomized discs implanted with PU 
scaffolds and FBG-HA hydrogel with/without BMP-2/7 under repetitive dynamic load. Mean 
± SEM, n=6. (B-C) Relative mRNA expression of cells in remaining native NP tissue and AF 
tissue in nucleotomized discs implanted with PU scaffolds and FBG-HA hydrogel 
with/without BMP-2/7 after 14 days of dynamic load. Data were normalized to the gene 
expression level of disc tissue from respective bovine tail before starting organ culture on day 
0. Mean + SEM, n=8.  
 
 
Figure 3. Representative Safranin O/Fast Green stained transverse sections of partially 
nucleotomized discs implanted with PU scaffolds and FBG-HA hydrogel with/without BMP-
2/7 after 14 days of dynamic load. (A, C) Overview of disc, scale bar: 1000 μm. (B, D) 
Interface between remaining NP tissue and implanted biomaterials with/without BMP-2/7, 
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scale bar: 50 μm. t – native disc NP tissue, e – the envelope of implanted PU scaffold, c – the 
core of implanted PU scaffold. 
 
 
A FTIR tissue distribution map 
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Figure 4. (A) Representative FTIR tissue distribution map of a paraffin embedded sagittal 
section of a partially nucleotomized disc implanted with PU scaffolds treated with hydrogel 
without BMP-2/7 (0 ng/mL BMP-2/7) cultured for 14 days under dynamic load. Image 
contrast for tissue distribution map is generated by integration of the 2nd derivative of the 
Amide III peak (1186-1297 cm-1). The black square indicates a region of interest (ROI) which 
was used to investigate the matrix distribution of native disc tissue surrounding the implant 
cavity. (B) FTIR tissue distribution maps of ROIs of a disc implanted with PU scaffolds 
treated with hydrogel without BMP-2/7 (top) and treated with 5000 ng/mL BMP-2/7 (bottom) 
cultured  for 14 days under dynamic load  (scale bar: white to black indicative of a low to high 
tissue content). (C) Estimated component per tissue distribution line profiles across the ROI 
normalised to 100 % IVD width for proteoglycan, collagen type II and collagen type I. 
 
